Rise Advisors’s Ardent Health ARDT Stock Holding History

Rise Advisors’s Portfolio ARDT Stock Details ARDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-48	Closed	-$636	–	1497
2025 Q3	$636	Buy	+48	New	+$600	﹤0.01%	1357

Other funds holding ARDT

CTC

Chai Trust Company Chicago, Illinois $1.45B AUM 10.17% 1-Year Est. Return

Ventas Inc Chicago, Illinois $91.9M AUM 27.96% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CastleKnight Management New York $7.38B AUM 133.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Rise Advisors's ARDT Position: Q4 2025 in Review

Rise Advisors sold out of Ardent Health (ARDT) in Q4 2025, closing a stake of 48 shares — an estimated $636 sold.

Rise Advisors first reported a position in ARDT in Q3 2025 and held it in 1 quarter. The position peaked at $636 in Q3 2025. 127 funds tracked by Wall St. Rank hold ARDT as of Q4 2025.

Rise Advisors reported no remaining Ardent Health position as of Q4 2025 after selling out during the quarter.
Rise Advisors sold 48 Ardent Health shares in Q4 2025, an estimated $636.
Rise Advisors first reported a position in Ardent Health in Q3 2025 and held it in 1 quarter.
Rise Advisors's Ardent Health position peaked at $636 in Q3 2025.
127 funds tracked by Wall St. Rank held Ardent Health as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.